Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Estimating the causal effect of body mass index on hay fever, asthma and lung function using Mendelian randomization

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020)

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. 2019 ARIA Care pathways for allergen immunotherapy

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Genetic Studies of Leptin Concentrations Implicate Leptin in the Regulation of Early Adiposity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The Danish severe asthma register: an electronic platform for severe asthma management and research

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Can we identify allergic rhinitis from administrative data: A validation study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Observational studies have shown that body mass index (BMI) is positively associated with asthma. However, observational data are prone to confounding and reverse causation. In Mendelian randomization, genetic variants are used as unconfounded markers of exposures to examine causal effects. We examined the causal effect of BMI on asthma, hay fever, allergic sensitization, serum total immunoglobulin E (IgE), forced expiratory volume in one-second (FEV1) and forced vital capacity (FVC).

METHODS: We included 490 497 participants in the observational and 162 124 participants in the genetic analyses. A genetic risk score (GRS) was created using 26 BMI-associated single nucleotide polymorphisms (SNPs). Results were pooled in meta-analyses and expressed as odds ratios (ORs) or β-estimates with 95% confidence interval (CI).

RESULTS: The GRS was significantly associated with asthma (OR=1.009; 95% CI: 1.004, 1.013), but not with hay fever (OR= 0.998; 95% CI: 0.994, 1.002) or allergic sensitization (OR=0.999; 95% CI: 0.986, 1.012) per BMI-increasing allele. The GRS was significantly associated with decrease in FEV1: β=-0.0012 (95% CI: -0.0019, -0.0006) and FVC: β=-0.0022 (95% CI: -0.0031, -0.0014) per BMI-increasing allele. Effect sizes estimated by instrumental variable analyses were OR=1.07 (95% CI: 1.03, 1.10) for asthma, a 9 ml decrease in FEV1 (95% CI: 2.0-15 mL decrease) and a 16 ml decrease in FVC (95% CI: 7.0-24 mL decrease) per 1 kg/m(2) higher BMI.

CONCLUSIONS: The results support the conclusion that increasing BMI is causally related to higher prevalence of asthma and decreased lung function, but not with hay fever or biomarkers of allergy.

OriginalsprogEngelsk
TidsskriftAllergy
Vol/bind73
Udgave nummer1
Sider (fra-til)153-64
ISSN0105-4538
DOI
StatusUdgivet - 2018

ID: 51731956